J67.7

Clinical Causes: Inhalation of fungal spores, including molds that grow in moist environments of air conditioning units and humidifiers. Presence of thermophilic actinomycetes, bacteria that flourish in warm, damp areas of ventilation systems. Other airborne microorganisms and particles originating from contaminated air conditioning and humidifier equipment. Poor maintenance or cleaning of indoor climate control devices, leading to the accumulation of microbial growth. Extended exposure in environments where air conditioning systems recirculate contaminated air.

Key Symptoms: Shortness of breath, especially after exposure to indoor climate-controlled environments. Persistent cough that may be dry or produce sputum. Fatigue and general feeling of malaise. Fever, chills, or sweats in more severe cases. Chest tightness or discomfort. Reduced exercise tolerance and difficulty breathing during physical activity. Rapid breathing or increased respiratory rate during episodes of inflammation.

Diagnosis Path: Diagnosis of air conditioner and humidifier lung involves a combination of clinical assessment and diagnostic testing. Medical professionals typically consider the patient's history of exposure to indoor climate control devices, particularly if symptoms worsen with prolonged exposure. Diagnostic procedures may include: - Chest X-ray or HRCT scan to identify patterns of lung inflammation. - Pulmonary function tests to assess lung capacity and airflow limitations. - Bronchoalveolar lavage (BAL) to analyze lung fluid for inflammatory cells. - Serum antibody tests to detect hypersensitivity responses against specific fungal or bacterial agents. - Environmental assessments of indoor air quality and ventilation systems to identify microbial contamination sources.

Treatment Protocols: Treating air conditioner and humidifier lung generally involves removing or minimizing exposure to the offending agents. This may include: - Discontinuing use of contaminated air conditioning or humidifier devices. - Thorough cleaning and maintenance of ventilation systems and humidifiers. - Use of high-efficiency particulate air (HEPA) filters to reduce airborne fungal spores and microorganisms. - Medications such as corticosteroids to reduce lung inflammation in more severe cases. - Supportive care, including oxygen therapy if breathing difficulty is significant. - Education on indoor air quality management and early recognition of symptoms for affected individuals. The primary goal is to eliminate exposure and prevent further lung damage, with medical follow-up to monitor recovery.